ADAM10 and colorectal carcinoma: Herein we determined that miR-365-3p was able to inhibit JAK-STAT signaling at least in part via targeting ADAM10, thereby suppressing the progression of CRC, thus highlighting a novel mode of JAK-STAT3 regulation.